Potential of induced pluripotent stem cells for the regeneration of the tracheal wall

Annals of Otology, Rhinology and Laryngology

Volumn 119, Issue 10, 2010, Pages 697-703

  Imaizumi, Mitsuyoshi ^a   Nomoto, Yukio ^a   Sugino, Takashi ^a   Miyake, Masao ^a   Wada, Ikuo ^a   Nakamura, Tatsuo ^b   Omori, Koichi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Bioengineered scaffold; Chondrogenesis; Induced pluripotent stem cell; Regeneration; Tracheal wall

Indexed keywords

COLLAGEN TYPE 2; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOENGINEERING; CARTILAGE CELL; CHONDROGENESIS; CONTROLLED STUDY; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RAT; TISSUE REGENERATION; TRACHEA;

EID: 77958043116     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941011901009     Document Type: Article

References (26)

1. Caputo V, Consiglio V. The use of patient's own auricular cartilage to repair deficiency of the tracheal wall. J Thorac Cardiovasc Surg 1961;41:594-6.
2. Cotton RT. Management of subglottic stenosis. Otolaryngol Clin North Am 2000;33:111-30.
3. Nakamura T, Teramachi M, Sekine T, et al. Artificial trachea and long-term follow-up in carinal reconstruction in dogs. Int J Artif Organs 2000;23:718-24.
4. Kawaguchi S, Nakamura T, Shimizu Y, et al. Mechanical properties of artificial tracheas composed of a mesh cylinder and a spiral stent. Biomaterials 2001;22:3085-90. (Pubitemid 32826216)
5. Omori K, Nakamura T, Kanemaru S, et al. Regenerative medicine of the trachea: the first human case. Ann Otol Rhinol Laryngol 2005;114:429-33. (Pubitemid 40840073)
6. Omori K, Tada Y, Suzuki T, et al. Clinical application of in situ tissue engineering using a scaffolding technique for reconstruction of the larynx and trachea. Ann Otol Rhinol Laryngol 2008;117:673-8.
7. Hartley BE, Cotton RT. Paediatric airway stenosis: laryngotracheal reconstruction or cricotracheal resection? Clin Otolaryngol Allied Sci 2000;25:342-9.
8. Gustafson LM, Hartley BE, Cotton RT. Acquired total (grade 4) subglottic stenosis in children. Ann Otol Rhinol Laryngol 2001;110:16-9.
9. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76.
10. Karumbayaram S, Novitch BG, Patterson M, et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009;27:806-11.
11. Senju S, Haruta M, Matsunaga Y, et al. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells 2009;27:1021-31.
12. Tashiro K, Inamura M, Kawabata K, et al. Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells 2009;27:1802-11.
13. Taura D, Sone M, Homma K, et al. Induction and isolation of vascular cells from human induced pluripotent stem cells - brief report. Arterioscler Thromb Vasc Biol 2009;29:1100-3.
14. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-7. (Pubitemid 47080336)
15. Akagi T, Sasai K, Hanafusa H. Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proc Natl Acad Sci U S A 2003;100:13567-72.
16. Hatsuzawa K, Tamura T, Hashimoto H, et al. Involvement of syntaxin 18, an endoplasmic reticulum (ER)-localized SNARE protein, in ER-mediated phagocytosis. Mol Biol Cell 2006;17:3964-77. (Pubitemid 44330880)
17. Steedman HF. Alcian blue 8GS: a new stain for mucin. J Cell Sci 1950;1:477-9.
18. Brittberg M. Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure. Am J Sports Med 2010;38:1259-71.
19. Ahrens M, Ankenbauer T, Schröder D, Hollnagel A, Mayer H, Gross G. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 1993;12:871-80.
20. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 1998;4:415-28.
21. Solchaga LA, Penick K, Goldberg VM, Caplan AI, Welter JF. Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A 2010;16:1009-19.
22. Kramer J, Hegert C, Guan K, Wobus AM, Müller PK, Rohwedel J. Embryonic stem cell-derived chondrogenic differentiation in vitro: activation by BMP-2 and BMP-4. Mech Dev 2000;92:193-205. (Pubitemid 30155914)
23. Wakitani S, Aoki H, Harada Y, et al. Embryonic stem cells form articular cartilage, not teratomas, in osteochondral defects of rat joints. Cell Transplant 2004;13:331-6. (Pubitemid 39163077)
24. Jukes JM, Moroni L, Van Blitterswijk CA, de Boer J. Critical steps toward a tissue-engineered cartilage implant using embryonic stem cells. Tissue Eng Part A 2008;14:135-47. (Pubitemid 351520431)
25. De Bari C, Dell'accio F, Luyten FP. Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum 2004;50:142-50.
26. Miura K, Okada Y, Aoi T, et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 2009;27:743-5.